Lower Back Pain: Why the Scan Shows Nothing, and How Four Countries Cope
Low back pain is the world's leading cause of disability, affecting 619 million people as of 2020. Yet of the people who bring chronic back pain to primary care, at least 90 percent are estimated to have primary back pain: no underlying disease or structural lesion reliably explains it. The guidelines' shared advice is unexpectedly simple. Keep moving within what the pain allows, try non-drug options like heat first, and skip routine imaging.
- 619 million people had low back pain in 2020, projected to reach 843 million by 2050. It is the leading cause of disability worldwide, and at least 90 percent of chronic cases seen in primary care are estimated to have no identifiable structural cause.
- Most acute and subacute back pain improves regardless of treatment. The American College of Physicians guideline puts non-drug care first: heat, massage, acupuncture, spinal manipulation. If medication is needed, NSAIDs or muscle relaxants.
- Bed rest is not recommended. Staying active within pain limits is the recommendation guidelines share.
- Occupational ergonomic factors, smoking and obesity explain about 39 percent of back-pain disability.
Contents
- Why do backs hurt
- What does the evidence support
- How do four countries frame the same ache
- United States: the guideline that made a U-turn
- Germany: a national disease with its own holiday
- Japan: the symptom at the top of the chart
- South Korea: a generation that moved from the floor to the chair
- What you can do today
- When to see a doctor
- Frequently asked questions
Why do backs hurt
The honest answer is the starting point of this article: in most cases, nobody knows precisely. By the estimate of WHO-affiliated researchers, at least 90 percent of the chronic back pain that arrives in primary care is chronic primary back pain, meaning pain lasting beyond three months that cannot be reliably attributed to an underlying disease or structural lesion. And as guideline after guideline repeats in one form or another, serious spinal pathology turns up in less than 1 percent of the back pain seen in primary care.
Unknown cause does not mean minor problem. Low back pain is the world's leading cause of disability, carried by 619 million people in 2020 and projected to reach 843 million by 2050. The risk-factor side is better mapped: occupational ergonomic factors, smoking and obesity together explain roughly 39 percent of the disability burden.
What does the evidence support
The reference document is the American College of Physicians' 2017 guideline, and it makes three moves.
First, most acute and subacute back pain gets better regardless of treatment. Second, when treating, non-drug options come first: heat, massage, acupuncture and spinal manipulation, with NSAIDs or muscle relaxants if medication is needed. Heat carries moderate-quality evidence for acute back pain, which is worth dwelling on for a moment. The heating pad turns out to be an evidence-backed option here just as it is for period pain; folk comforts are not automatically evidence-free. Third, a strong recommendation: do not order imaging routinely for nonspecific back pain. Most of the time, the answer is not in the picture.
And one sentence runs through the guidelines: stay active within what the pain allows. Bed rest is not recommended. The oldest piece of back-pain folklore, lie down until it passes, points the wrong way.
One more thing to settle early. We found no evidence establishing that prolonged sitting causes disc disease. Studies on sitting and back pain point in different directions, so this article treats posture as a possible trigger or aggravator, not a cause.
How do four countries frame the same ache
Everyone's back hurts. What differs is what kind of problem each country decided the ache is.
| Country | Scale of the problem | What the country actually does | Level of evidence |
|---|---|---|---|
| United States | A quarter of adults report back pain within any three months | Guidelines steering care from drugs to non-drug options | Medical, guideline |
| Germany | 61.3 percent of adults affected within a year | Framed as a national disease, with an annual awareness day | Practice, RKI |
| Japan | The top self-reported symptom for both sexes | Managed as an occupational health issue | Practice, government survey |
| South Korea | Disc-disorder patients around two million a year (about 2.08 million in 2014) | Hospital-access centered | Practice, HIRA |
Table: the scale of back pain and national responses compared. Each country's answer mirrors its healthcare system's character.
United States: the guideline that made a U-turn
USBack pain is among the most common reasons Americans see a doctor, with about a quarter of adults reporting at least one day of it in any three-month window.
The American story is the 2017 guideline itself. When the ACP put non-drug treatment first and pinned opioids as a last resort, the background was the country's opioid crisis. In a system where pain management had hardened around prescriptions, back pain became the flagship case for steering care back toward movement and non-drug options. Measure the distance between the old default, scan and prescribe, and the new instruction, keep moving, skip the routine scan, opioids last, and you have the size of what American medicine learned from this one symptom.
Germany: a national disease with its own holiday
DEGermany talks about back pain in the vocabulary of a Volkskrankheit, a national disease. In the Robert Koch Institute's burden-of-disease study, 61.3 percent of adults had experienced back pain within the previous twelve months, 66.0 percent of women and 56.4 percent of men, with lower back pain (52.9 percent) about twice as common as upper (27.4 percent).
Every March 15 is Back Health Day, Tag der Rückengesundheit, and the RKI times publications to it. The design carries a judgment: when two in three people share a symptom, it is a population problem, not a personal one, and it gets a campaign rather than a lecture.
Japan: the symptom at the top of the chart
JPIn Japan, back pain sits at the top of the national statistics. In the 2022 Comprehensive Survey of Living Conditions, it ranked first among self-reported symptoms for both sexes, at 91.6 per thousand men and 113.8 per thousand women.
The character of the response differs from its neighbors. The health ministry maintains a workplace back-pain prevention guideline and manages the condition as an occupational health issue for lifting-heavy sectors like caregiving and transport. Back pain is registered as a workplace problem, not only a personal ailment. Japan is also a country of tatami floors and formal kneeling, but we found no reliable research linking the kneeling posture to back pain, so it stays a cultural note and nothing more.
South Korea: a generation that moved from the floor to the chair
KRThe numbers first. By national claims data, about 2.08 million Koreans were treated for disc disorders (other intervertebral disc disorders) in 2014, up 20.4 percent over five years, with people in their fifties the largest group. From 2015 to 2017 the count grew by another 60,000, and 56.8 percent of patients were women. Around two million people a year see a doctor under this one diagnosis.
The cultural backdrop is a change in how Koreans sit. Traditional life happened on heated ondol floors, cross-legged, a posture long cited as hard on the back; the review agency's own press materials mention holiday gatherings spent working while seated on the floor as a strain factor. That generation now shares households with one that spends its days in office chairs. Floor-sitting strain and long office sitting differ in form, and neither has a settled causal verdict. What is certain is only that the shape of the burden changed within a single generation.
Overlay the four responses and you get four self-portraits. Korea answers with hospital access, Japan with occupational health, Germany with a prevention campaign, and the United States with a correction to its own prescribing culture. Same ache, four mirrors.
What you can do today
This section stays inside what the ACP's 2017 guideline recommends, and it applies to the ordinary case: acute or subacute back pain that does not match anything in "When to see a doctor" below.
Do not lie down and wait. Stay active within what the pain allows is the sentence the guidelines share, and bed rest is not recommended. The conditional clause carries the weight. This is not an instruction to push through pain; it is an instruction to find the range the pain allows and move inside it.
Try heat first. The ACP guideline puts non-drug options ahead of medication, and its list is heat, massage, acupuncture and spinal manipulation. Of those, heat carries moderate-quality evidence for acute back pain. The same pattern holds for period pain, where a meta-analysis of 57 trials found topical heat may match NSAIDs for relief: folk comforts are not automatically evidence-free.
Factor in that most of this resolves on its own. Most acute and subacute back pain improves regardless of treatment. That is the reason to start with the low-risk options, and also the reason to be careful about crediting whatever you happened to try.
Do not ask for a scan. Do not order imaging routinely for nonspecific back pain is a strong recommendation in this guideline, because most of the time the answer is not in the picture. Warning signs change that calculation, and that call comes out of an examination.
Leave the medication question to a consultation. This article names no drugs and no doses. Whether to use one is decided alongside other conditions, and that is not a decision that resolves outside a clinic.
One matter of order: if anything in the next section applies to you, that section comes before this list.
When to see a doctor
Medicine's term for "this may not be just a muscle" is the red flag, and it turns out the list differs by country. A 2016 review that compared 16 low back pain guidelines from 15 countries found 46 distinct red flags spread across four categories of serious pathology: malignancy, fracture, cauda equina syndrome and infection. Many of the 46 appeared in only a single country's guideline.
What most guidelines agreed on was four items: significant trauma, use of steroids or immunosuppressants, a history of cancer, and unintentional weight loss. Pain at night or at rest was also the most commonly cited warning sign across underlying pathologies.
A national guideline says the same thing in its own words. NICE's guideline on low back pain and sciatica, published in 2016, updated in 2020 and amended in 2022, tells clinicians to think about alternative diagnoses when examining or reviewing someone with back pain, particularly when symptoms are new or have changed, and to exclude specific causes such as cancer, infection, trauma, and inflammatory disease like spondyloarthritis.
The same guideline also draws one line that deserves its own paragraphs. It excludes cauda equina syndrome and progressive neurological deficit from its scope entirely, calling them potential neurological emergencies that every clinician managing sciatica must be able to recognise, and must know when to refer. A guideline stepping outside its own remit to flag something is not a common sight.
Cauda equina syndrome is a rare condition in which the bundle of nerves at the base of the spine is compressed, most often by a herniated disc. Unrecognised or treated late, it can end in permanent loss of bladder, bowel and sexual function, or paralysis of the legs; treated before symptoms worsen, the risk of permanent damage falls. The threshold is not how much the back hurts. It is new nerve symptoms below the waist. Whether sensation has changed in the saddle area, around the genitals and anus. Whether starting or stopping urination has become difficult. Whether bowel control has slipped. Whether both legs are weakening together.
An NHS hospital's patient guidance closes the point better than we could: the most important thing to do when cauda equina syndrome is suspected is to go to emergency care and be assessed by a clinician. The condition can only be confirmed or ruled out by a spine MRI. It is not a call anyone can make on themselves.
For the rest of the list, one caution applies. These are screening prompts clinicians use during an examination, not a checklist for readers to self-diagnose against, and the 2016 review found the accuracy evidence behind individual red flags to be uneven. The headache equivalent carries the same warning from its own authors: the SNNOOP10 red-flag list shifts probabilities rather than delivering verdicts, and the prospective studies behind it are missing. The correct use of this list is simple: if something on it applies, defer your own judgment and get examined. Separately from the flags, pain that lasts beyond a few weeks or keeps escalating deserves an appointment, and even then the order stands: examination before imaging, and most back pain is managed without a picture.
Frequently asked questions
Frequently asked
Is back pain really the world's top cause of disability?
Yes, by the Global Burden of Disease work: the leading cause of disability worldwide, with 619 million people affected in 2020 and 843 million projected for 2050. The scale is part of why guidelines argue against routing every case through scans and strong drugs.
Why did US guidelines turn away from medication?
The 2017 ACP guideline made non-drug care first-line and opioids a last resort, against the backdrop of the opioid crisis. Since most acute back pain improves on its own, the guideline reads as an attempt to stop the harms of overtreatment from outrunning the harms of the pain.
My scan found nothing. Is my pain not real?
It is real, and it is also typical: at least 90 percent of the chronic back pain seen in primary care is estimated to have no scan finding that explains it. That is exactly why routine imaging is discouraged. A clean scan does not mean nothing hurts; it means the picture was never where the answer lived.
Does heat actually help a bad back?
Heat carries moderate-quality evidence for acute low back pain in the ACP guideline, making it one of the better-supported simple options, alongside staying active. The same pattern shows up for period pain: the heating pad is folk advice that happens to have receipts.
- WHO. Low back pain fact sheet, June 2023
- GBD 2021 Low Back Pain Collaborators. Lancet Rheumatology, 2023; IHME press release
- Briggs AM et al. The WHO guideline for non-surgical management of chronic primary low back pain in adults. Global Health Research and Policy, 2025 (the 90 percent estimate)
- NICE. Low back pain and sciatica in over 16s: assessment and management (NG59), published 2016, updated 2020, amended 2022
- Buckinghamshire Healthcare NHS Trust. Cauda Equina Syndrome patient information
- Verhagen AP et al. Red flags presented in current low back pain guidelines: a review. European Spine Journal, 2016
- Saudi clinical practice guideline on low back pain and sciatica (source of the "less than 1 percent" phrasing)
- Qaseem A et al. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain. Annals of Internal Medicine, 2017; ACP press release; AAFP summary
- Ministry of Health and Welfare (Korea) and HIRA. Press releases on disc-disorder treatment figures, 2015 and 2018
- Ministry of Health, Labour and Welfare (Japan). 2022 Comprehensive Survey of Living Conditions, overview
- Ministry of Health, Labour and Welfare (Japan). Workplace back-pain prevention guideline
- Robert Koch-Institut. Journal of Health Monitoring S3/2021, BURDEN 2020
- Ärzte Zeitung. Coverage of Back Health Day
This article is for information only and does not replace diagnosis or treatment. Decisions about medication belong with a clinician. If red-flag signs appear, numbness in a leg, loss of bladder or bowel control, seek care without delay. Medical disclaimer
Read next
Hair Loss Treatment: What Works, and Why the Warnings Differ by Country
Topical minoxidil and oral finasteride are the FDA-approved options. Japan grades every treatment A to D, and UK regulators strengthened warnings in May 2026.
Insomnia Treatment: Why the Guidelines Put CBT-I Before Sleeping Pills
First-line treatment for chronic insomnia is CBT-I, not medication, and the 2026 guideline advises against adding sleeping pills to it.
Period Pain Relief That Actually Works: The Guideline Says Stop Normalizing It
First-line treatment for dysmenorrhea is NSAIDs and hormonal contraception, and the SOGC guideline says the condition is frequently normalized and undertreated.